Advertisement

Decreased Expression of Stomatin Predicts Poor Prognosis in HER2-Positive Breast Cancer

Stomatin expression was an independent prognostic indicator from trastuzumab treatment, with a higher hazard ratio than that of adjuvant trastuzumab.

 BMC Cancer

click me